Rising biosimilar adoption, shifting market dynamics, and escalating supply chain vulnerabilities are driving change in ...

GLP-1 receptor agonists and SGLT2 inhibitors are associated with a lower risk of dementia, suggesting these drugs may have a ...

Benefits advisors need to stay proactive and help their clients leverage formulary design, clinical oversight, and ...

Walgreens , which is in the process of being taken private by Sycamore Partners, beat Wall Street estimates for quarterly ...

Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to ...

Purpose: The pathophysiology, diagnosis, complications, and management of gestational diabetes mellitus (GDM) are discussed, along with considerations in setting up a pharmacist-run GDM education ...

A growing emphasis on compounding and personalized medicine is driving a complete revolution in the retail pharmacy market.

Insulin: In 2019, employer plan participants who used insulin spent an average of $82 per month out-of-pocket on their ...

LucyRx, a next-generation pharmacy benefits manager (PBM), announced the expansion of its network of specialty pharmacies.

Chief Executive Tim Wentworth said the second-quarter results reflected cost management and improvement in U.S. healthcare, though partially offset by weaker front-rend results in U.S. retail pharmacy ...

Common gut bacteria can metabolise some oral medications potentially rendering these important drugs against migraines, ...

Learn more about whether Organon & Co. or Viatris Inc. is a better investment based on AAII's A+ Investor grades, which ...